Drug interactions
Alogliptin-pioglitazone + Insulin degludec
Severity: Major
Alogliptin-pioglitazone and Insulin degludec: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Combining insulin with pioglitazone increases the risk of edema and heart failure, and the glucose-lowering effects are additive, raising hypoglycemia risk.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-pioglitazone and Insulin degludec interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Alogliptin-pioglitazone
Other interactions of Insulin degludec
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
